Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

Dr. Joseph A. Moore received his medical degree from the University of Kansas School of Medicine. He completed his Internal Medicine residency at the University of Texas Southwestern Medical Center in Dallas, TX. Subsequently, he completed his fellowship in Hematology and Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, serving as Chief Oncology fellow in his …
AMA's Drug Evaluations Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 AMA's Drug Evaluations Carol Proudfit To cite this article: Carol Proudfit (1994) AMA's Drug Evaluations, Oncology …
I have been the Gundersen Health System Cancer Center Director for 10 years. In that period, I have seen many changes driving cancer care within our organization such as precision medicine, staffing shortages, changing treatment paradigms and re-imbursement models just to name a few. In this process of change, cancer care has become a much more complex disease with multiple providers routinely involved …
tools 96 OI | Vol. 39, No. 3, 2024 | accc-cancer.org granted fast-track designation to CTX-009 in combination with paclitaxel for the treatment of patients with metastatic or locally advanced biliary tract cancer that has been previously treated. ● GSK, PLC (gsk.com) announced the FDA accepted the supplemental biologics license application (BLA) for Jemperli® (dostarlimab) in combination …
Fox Chase Cancer Center CAR T-cell Practice Profile This article explores the approach that Fox Chase Cancer Center took to deliver CAR T-cell therapies for patients from community cancer programs and its lessons learned. Fox Chase Cancer Center at Temple University Hospital, Philadelphia, PA, is a national leader in cancer research and treatment. Henry Chi Hang Fung, MD, FACP, …
SO10-Academic-Medical-Physics-at-Mary-Bird-Perkins-Cancer-Center
ND08-First-Person
ACCC Capitol Hill Day Issue Briefs—March 20, 2019 CANCER DRUG PARITY ACT (H.R. 1730 / S.741) BACKGROUND: Traditionally, intravenous (IV) and injected treatments were the primary methods of chemotherapy delivery. Today, patient-administered chemotherapy has become more prevalent and is the standard of care for many types of cancer. But insurance coverage has not kept pace with …
SO06-Perspectives-from-an-Oncologist-in-an-Outpatient-Oncology-Clinic
ND09-Editor
MJ04-President
February [XX], 2022 Wisconsin Assembly Committee on Health Wisconsin State Capitol 2 East Main Street Madison, Wisconsin 53703 RE: Support Assembly Bill 184 to Protect Copay Assistance for Patients Dear Chairman Sanfelippo and members of the Committee: On behalf of [ORGANIZATION], [I am/we are] writing to you today to thank the Wisconsin Assembly Committee on Health for …
Do's & Don'ts of Capitation Contracting Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Do's & Don'ts of Capitation Contracting John B. Benear II To cite this article: John B. Benear …
ACCC Immuno-Oncology Institute Executive Committee Chair Lee Schwartzberg, MD, FACP, highlights his top picks for compelling, potentially practice-changing immunotherapy abstracts presented during the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. Dr. Schwartzberg is Chief, Division of Hematology Oncology; Professor of Medicine, University of Tennessee; and Executive Director, West …
Many types of biological products are used therapeutically and for supportive care for patients with cancer. Biologics are large, complex molecules that are produced by biotechnology in a living system (for example, a microorganism, plant, or animal cell). The U.S. Food and Drug Administration (FDA) regulates and approves biological products, which include therapeutic proteins and monoclonal …
As oncology engages in value-based reimbursement, new payment models, and precision medicine, oncology pharmacists and pharmacy staff are integral to the successful delivery of quality, cost-effective patient care.
ND02-Tools